12 - 73 - PANNICULITIS Flashcards

1
Q
A

Erythema nodosum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
A

Erythema induratum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A

Lipodermatosclerosis

(sclerosing panniculitis, hypodermitis, sclerodermiformis, chronic panniculitis with lipomembranous changes, sclerotic atrophic cellulitis, venous stasis panniculitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
A

Infectious panniculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
A

α1 -Antitrypsin panniculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A

Pancreatic panniculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A

Lupus panniculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A

Panniculitis with dermatomyositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A

Cytophagic histiocytic panniculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A

Subcutaneous fat necrosis of the newborn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
A

Cold panniculitis (Haxthausen disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A

Factitial panniculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

differentiate septal and lobular panniculitis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

the prototypic septal panniculitis

A

Erythema nodosum (EN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

most commonly involved area in erythema nodosum

A

anterior lower legs and ankles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

most common etiology in pediatric cases of EN

A

streptococcal respiratory tract infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

EN has characteristic, but not sensitive or specific, groupings of histiocytes surrounding a central stellate cleft called

A

Miescher granuloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

mainstay of treatment of EN after removing or treating the provoking factors

A

Supportive care

  • bed rest if severe, with lower-extremity elevation, and nonsteroidal antiinflammatory agents are recommended.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

effective in Behçet-related EN

A

Colchicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

options for inflammatory bowel disease–associated EN

A

Etanercept and infliximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Erythematous subcutaneous nodules and plaques of lower legs; common on calves, but also on anterolateral legs, feet, and thighs; rarely also on arms, forearms, and face

A

ERYTHEMA INDURATUM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Associated with venous insufficiency

A

ERYTHEMA INDURATUM

23
Q

erythema induratum is most commonly associated with what infection?

24
Q

most commonly presents with ulcerated nodules on the calves, and is associated with MTB infection

A

Erythema induratum (EI)

25
Q

ulcerated nodules on the calves without MTB association

A

nodular vasculitis (NV)

26
Q

most common diagnosis of a panniculitis with vasculitis

A

EI/NV grouping

27
Q

lesions develop more frequently during winter, and are associated with obesity and venous insufficiency

A

erythema induratum

28
Q

common finding in erythema induratum histopath

A

mostly lobular or mixed septal and lobular panniculitis

29
Q

Indurated, firm plaques of wood-like consistency on the lower legs.

A

LIPODERMATOSCLEROSIS

30
Q

the most common form of panniculitis

A

Lipodermatosclerosis (LDS)

31
Q

best site for biopsy of lipodermatosclerosis

A

proximal edge of involvement for highest rates of healing

32
Q

first line treatment for LDS

A

compression therapy

  • contraindicated in patients with arterial compromise
  • Higher compression gradient (30 to 40 mm Hg) may be more effective, but lower pressure (15 to 20 mm Hg or 20 to 30 mm Hg) encourages compliance
  • Compression tightens vascular tight junctions, inhibiting permeability of fluid into the perivascular tissue
  • must be worn all day; a few days without compression may lead to recurrence of edema and inflammation
33
Q

most common sites of infection of infection-induced panniculitis

A

legs and feet

but upper extremities, trunk, and face also may be involved

34
Q

most frequent association with infection-induced panniculitis

A

immunosuppression of varying etiology

34
Q

histopath findings of infection-induced panniculitis

A

A mostly lobular panniculitis, IIP often reveals a **mixed septal and lobular pattern. **

The superficial dermis has more inflammation in infections acquired by direct inoculation, while infections secondary to hematogenous spread involve the deep reticular dermis and subcutaneous fat

35
Q

most common phenotype to induce α1-Antitrypsin (α1AT) panniculitis

A

ZZ-phenotype

Homozygous MM represents 90% to 97% of the population

36
Q
  • Patients present with painful erythematous nodules and plaques, but early lesions may have a cellulitic or fluctuant abscess-type appearance
  • Lesions may ulcerate with oily or serosanguinous discharge and resolve with atrophic scars
A

α1-Antitrypsin panniculitis

37
Q

area of predilection of α1-Antitrypsin panniculitis

A

lower trunk (buttocks) and proximal extremities

but the lower legs and other sites may be affected

38
Q

phenotype that is at highest risk for associated with **pulmonary and hepatic disease, **leading to chronic obstructive pulmonary disease, hepatic cirrhosis, or hepatocellular carcinoma

A

ZZ phenotype

39
Q

early and distinctive diagnostic clue for α1-Antitrypsin panniculitis

A

splaying of neutrophils between collagen bundles throughout the overlying reticular dermis

40
Q

**“floating” necrotic fat lobules ** from liquefactive necrosis and dissolution of dermal collagen may be accompanied by ulceration, and degeneration of elastic tissue may lead to septal destruction may be seen in what type of panniculitis

A

area of predilection of α1-Antitrypsin panniculitis

41
Q

areas of predilection of pancreative panniculitis

A

lower legs, especially the periarticular areas

also on the arms, wrists, thighs, and trunk

42
Q

potential markers of extrapancreatic fat necrosis

A

Resistin and leptin

43
Q

ghost cells are seen in what panniculitis?

A

Pancreatic panniculitis

Adipocytes lose their nuclei but maintain peripheral outlines, forming characteristic “ghost cells”

44
Q

important prognostic indicator in lupus panniculitis

A

CD123-positive staining

CD123 immunohistochemical staining can be a helpful prognostic indicator, as a higher percentage of CD123 positive cells has a** greater response to steroid therapy**

45
Q

first-line treatment of lupus erythematosus panniculitis and may be the only medications needed

A

Antimalarials

  • When monotherapy with hydroxychloroquine is ineffective, combination with quinacrine has been used successfully but is difficult to obtain
  • interfere with both inflammatory cytokines and TLRs
  • Antimalarials have a diminished effect in smokers
46
Q

characteristic cell seen in Cytophagic histiocytic panniculitis (CHP)

A

Phagocytic histiocytes contain intact or fragmented cells and nuclear debris within their cytoplasm; this represents the characteristic “beanbag cell”

46
Q

difference of beanbag cells from emperipolesis

A
  • “beanbag cell” - phagocytic histiocytes contain** intact or fragmented cells** and nuclear debris within their cytoplasm
    *emperipolesis - (the presence of an **intact cell within the cytoplasm of another cell) in which inflammatory cells pass through a histiocyte and no nuclear debris **is seen
46
Q

medications that are often used and are often successful in treating Cytophagic histiocytic panniculitis (CHP)

A

cyclosporine and corticosteroids

47
Q

■ Subcutaneous erythematous to violaceous plaques and nodules on extremities, trunk, and less frequently elsewhere; lesions may ulcerate.

■ Fever, hepatosplenomegaly, 2 or more cytopenias; hemocytophagocytosis in bone marrow, lymph nodes, liver, or CNS.

■ Hypertriglyceridemia, ferritin >500 mg/L; increased soluble CD25, CD163 levels.

A

Cytophagic histiocytic panniculitis (CHP)

48
Q

histopath findings of Subcutaneous fat necrosis of the newborn (SCFN)

A
  • Mostly lobular panniculitis without vasculitis.
  • Dense inflammatory infiltrate of lymphocytes, histiocytes, lipophages, and multinucleated giant cells.
  • Needle-shaped clefts, often in radial array, within cytoplasm of histiocytes and multinucleated giant cells.
49
Q

The most common complication of Subcutaneous fat necrosis of the newborn (SCFN)

A

hypercalcemia

  • The hypercalcemia may be related to increased 25-hydroxyvitamin D3 –1α hydroxylase within the granulomatous infiltrates.
  • Rarely, hypertriglyceridemia, hypoglycemia, thrombocytopenia, anemia.
50
Q

the most severe potential adverse outcome of histopath findings of Subcutaneous fat necrosis of the newborn (SCFN) and may cause nephrocalcinosis

A

Hypercalcemia

51
Q

needle-shaped clefts can be seen in what disorders

A
  • subcutaneous fat necrosis of the newborn
  • sclerema neonatorum
  • post-steroid panniculitis